https://modconpak.com/wp-content/uploads/2017/11/1-6.jpg
A third of leukaemia patients do not generate antibody response to two doses of COVID-19 vaccination

Dr Helen Parry describes the findings of a new University of Birmingham-led study which has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination. Furthermore, the research showed that in the two thirds of patients who do develop antibodies, levels are much lower than compared to healthy people and also have a profoundly reduced ability to ‘neutralise’ the globally dominant Delta variant.

Find out more at: https://www.birmingham.ac.uk/news/latest/2021/10/covid-vaccination-leukaemia-antibody-response.aspx

Leave a Reply

Your email address will not be published. Required fields are marked *